Deskripsi

Safety data for the Lactobacillus casei drink in critically ill ICU patients demonstrate tolerability and absence of probiotic-related adverse events.

Figure 4

Chart

Source Paper

Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile.

Nutrients (2018)

PMID: 29701662

DOI: 10.3390/nu10050539

Cite This Figure

![Figure 4: Safety data for the Lactobacillus casei drink in critically ill ICU patients demonstrate tolerability and absence of probiotic-related adverse events.]()

> Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." *Nutrients*, 2018. PMID: [29701662](https://pubmed.ncbi.nlm.nih.gov/29701662/)

<figure>
  <img src="" alt="Safety data for the Lactobacillus casei drink in critically ill ICU patients demonstrate tolerability and absence of probiotic-related adverse events." />
  <figcaption>Figure 4. Safety data for the Lactobacillus casei drink in critically ill ICU patients demonstrate tolerability and absence of probiotic-related adverse events.<br>  Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29701662/">29701662</a></figcaption>
</figure>

Bukti Terkait

Lactobacillus casei untuk Antibiotic-Associated Diarrhea (AAD)

Peringkat C · 3 studi